{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:17:40Z","timestamp":1787019460014,"version":"build-2736575974"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T00:00:00Z","timestamp":1630022400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T00:00:00Z","timestamp":1630022400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s10875-021-01112-5","type":"journal-article","created":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T02:02:54Z","timestamp":1630029774000},"page":"1865-1877","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Hematopoietic Cell Transplantation for Severe Combined Immunodeficiency Patients: a Japanese Retrospective Study"],"prefix":"10.1007","volume":"41","author":[{"given":"Satoshi","family":"Miyamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsutsugu","family":"Umeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mio","family":"Kurata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakatsu","family":"Yanagimachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Ishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maho","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomonari","family":"Shigemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motohiro","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoji","family":"Sasahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Iguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Koike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiko","family":"Kajiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masami","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiko","family":"Hashii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromasa","family":"Yabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiko","family":"Atsuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2132-8403","authenticated-orcid":false,"given":"Kohsuke","family":"Imai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Morio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,27]]},"reference":[{"key":"1112_CR1","doi-asserted-by":"publisher","first-page":"3749","DOI":"10.1182\/blood-2013-02-380105","volume":"122","author":"HB Gaspar","year":"2013","unstructured":"Gaspar HB, Qasim W, Davies EG, Rao K, Amrolia PJ, Veys P. How I treat severe combined immunodeficiency. Blood. 2013;122:3749\u201358. https:\/\/doi.org\/10.1182\/blood-2013-02-380105.","journal-title":"Blood"},{"key":"1112_CR2","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s10875-020-00758-x","volume":"40","author":"SG Tangye","year":"2020","unstructured":"Tangye SG, Al-Herz W, Bousfiha A, Chatila T, Cunningham-Rundles C, Etzioni A, et al. Human inborn errors of immunity: 2019 update on the classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol. 2020;40:24\u201364. https:\/\/doi.org\/10.1007\/s10875-020-00758-x.","journal-title":"J Clin Immunol"},{"key":"1112_CR3","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1016\/s0140-6736(68)92673-1","volume":"2","author":"RA Gatti","year":"1968","unstructured":"Gatti RA, Meuwissen HJ, Allen HD, Hong R, Good RA. Immunological reconstitution of sex-linked lymphopenic immunological deficiency. Lancet. 1968;2:1366\u20139. https:\/\/doi.org\/10.1016\/s0140-6736(68)92673-1.","journal-title":"Lancet"},{"key":"1112_CR4","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/j.1365-2141.2011.08735.x","volume":"154","author":"T Morio","year":"2011","unstructured":"Morio T, Atsuta Y, Tomizawa D, Nagamura-Inoue T, Kato K, Ariga T, et al. Outcome of unrelated umbilical cord blood transplantation in 88 patients with primary immunodeficiency in Japan. Br J Haematol. 2011;154:363\u201372. https:\/\/doi.org\/10.1111\/j.1365-2141.2011.08735.x.","journal-title":"Br J Haematol"},{"key":"1112_CR5","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/sj.bmt.1705273","volume":"37","author":"Y Tsuji","year":"2006","unstructured":"Tsuji Y, Imai K, Kajiwara M, Aoki Y, Isoda T, Tomizawa D, et al. Hematopoietic stem cell transplantation for 30 patients with primary immunodeficiency diseases: 20 years experience of a single team. Bone Marrow Transplant. 2006;37:469\u201377. https:\/\/doi.org\/10.1038\/sj.bmt.1705273.","journal-title":"Bone Marrow Transplant"},{"key":"1112_CR6","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1038\/bmt.2010.338","volume":"46","author":"A Iguchi","year":"2011","unstructured":"Iguchi A, Kawamura N, Kobayashi R, Takezaki S-I, Ohkura Y, Inamoto J, et al. Successful reduced-intensity SCT from unrelated cord blood in three patients with X-linked SCID. Bone Marrow Transplant. 2011;46:1526\u201331. https:\/\/doi.org\/10.1038\/bmt.2010.338.","journal-title":"Bone Marrow Transplant"},{"key":"1112_CR7","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s12185-013-1408-7","volume":"98","author":"S Kumaki","year":"2013","unstructured":"Kumaki S, Sasahara Y, Kamachi Y, Muramatsu H, Morio T, Goi K, et al. B-cell function after unrelated umbilical cord blood transplantation using a minimal-intensity conditioning regimen in patients with X-SCID. Int J Hematol. 2013;98:355\u201360. https:\/\/doi.org\/10.1007\/s12185-013-1408-7.","journal-title":"Int J Hematol"},{"key":"1112_CR8","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1182\/blood-2011-06-363572","volume":"119","author":"JF Fernandes","year":"2012","unstructured":"Fernandes JF, Rocha V, Labopin M, Neven B, Moshous D, Gennery AR, et al. Transplantation in patients with SCID: mismatched related stem cells or unrelated cord blood? Blood. 2012;119:2949\u201355. https:\/\/doi.org\/10.1182\/blood-2011-06-363572.","journal-title":"Blood"},{"key":"1112_CR9","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1532\/IJH97.06239","volume":"86","author":"Y Atsuta","year":"2007","unstructured":"Atsuta Y, Suzuki R, Yoshimi A, Gondo H, Tanaka J, Hiraoka A, et al. Unification of hematopoietic stem cell transplantation registries in Japan and establishment of the TRUMP System. Int J Hematol. 2007;86:269\u201374. https:\/\/doi.org\/10.1532\/IJH97.06239.","journal-title":"Int J Hematol"},{"key":"1112_CR10","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s10875-017-0465-8","volume":"38","author":"A Bousfiha","year":"2017","unstructured":"Bousfiha A, Jeddane L, Picard C, Ailal F, Gaspar HB, Al-Herz W, et al. The 2017 IUIS Phenotypic Classification for Primary Immunodeficiencies. J Clin Immunol. 2017;38:129\u201343. https:\/\/doi.org\/10.1007\/s10875-017-0465-8.","journal-title":"J Clin Immunol"},{"key":"1112_CR11","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1056\/NEJMoa1401177","volume":"371","author":"S-Y Pai","year":"2014","unstructured":"Pai S-Y, Logan BR, Griffith LM, Buckley RH, Parrott RE, Dvorak CC, et al. Transplantation outcomes for severe combined immunodeficiency, 2000\u20132009. N Engl J Med. 2014;371:434\u201346. https:\/\/doi.org\/10.1056\/NEJMoa1401177.","journal-title":"N Engl J Med"},{"key":"1112_CR12","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1182\/blood-2018-03-840702","volume":"132","author":"E Haddad","year":"2018","unstructured":"Haddad E, Logan BR, Griffith LM, Buckley RH, Parrott RE, Prockop SE, et al. SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery. Blood. 2018;132:1737\u201349. https:\/\/doi.org\/10.1182\/blood-2018-03-840702.","journal-title":"Blood"},{"key":"1112_CR13","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.jaci.2010.06.015","volume":"126","author":"AR Gennery","year":"2010","unstructured":"Gennery AR, Slatter MA, Grandin L, Taupin P, Cant AJ, Veys P, et al. Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: entering a new century, do we do better? J Allergy Clin Immunol. 2010;126:602\u201310. https:\/\/doi.org\/10.1016\/j.jaci.2010.06.015.","journal-title":"J Allergy Clin Immunol"},{"key":"1112_CR14","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics. Bone Marrow Transplant. 2013;48:452\u20138. https:\/\/doi.org\/10.1038\/bmt.2012.244.","journal-title":"Bone Marrow Transplant"},{"key":"1112_CR15","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1007\/s10875-019-00610-x","volume":"39","author":"A Ikinciogullari","year":"2019","unstructured":"Ikinciogullari A, Cagdas D, Dogu F, Tugrul T, Karasu G, Haskologlu S, et al. Clinical features and HSCT outcome for SCID in Turkey. J Clin Immunol. 2019;39:316\u201323. https:\/\/doi.org\/10.1007\/s10875-019-00610-x.","journal-title":"J Clin Immunol"},{"key":"1112_CR16","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.bbmt.2012.11.619","volume":"19","author":"R Mitchell","year":"2013","unstructured":"Mitchell R, Nivison-Smith I, Anazodo A, Tiedemann K, Shaw P, Teague L, et al. Outcomes of hematopoietic stem cell transplantation in primary immunodeficiency: a report from the Australian and New Zealand Children\u2019s Haematology Oncology Group and the Australasian Bone Marrow Transplant Recipient Registry. Biol Blood Marrow Transplant. 2013;19:338\u201343. https:\/\/doi.org\/10.1016\/j.bbmt.2012.11.619.","journal-title":"Biol Blood Marrow Transplant"},{"key":"1112_CR17","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.bbmt.2015.12.027","volume":"22","author":"J Kanda","year":"2016","unstructured":"Kanda J, Brazauskas R, Hu Z-H, Kuwatsuka Y, Nagafuji K, Kanamori H, et al. Graft-versus-host disease after HLA-matched sibling bone marrow or peripheral blood stem cell transplantation: comparison of North American Caucasian and Japanese populations. Biol Blood Marrow Transplant. 2016;22:744\u201351. https:\/\/doi.org\/10.1016\/j.bbmt.2015.12.027.","journal-title":"Biol Blood Marrow Transplant"},{"key":"1112_CR18","doi-asserted-by":"publisher","first-page":"e325","DOI":"10.1016\/S2352-3026(17)30104-7","volume":"4","author":"M Eapen","year":"2017","unstructured":"Eapen M, Wang T, Veys P, Boelens J, St Martin A, Spellman S, et al. Allele-level HLA matching for umbilical cord blood transplantation for non-malignant diseases in children: a retrospective analysis. Lancet Haematol. 2017;4:e325\u201333. https:\/\/doi.org\/10.1016\/S2352-3026(17)30104-7.","journal-title":"Lancet Haematol"},{"key":"1112_CR19","doi-asserted-by":"publisher","first-page":"4664","DOI":"10.1182\/blood-2009-10-251157","volume":"115","author":"S Morishima","year":"2010","unstructured":"Morishima S, Ogawa S, Matsubara A, Kawase T, NannyaYmKashiwase K, et al. Impact of highly conserved HLA haplotype on acute graft-versus-host disease. Blood. 2010;115:4664\u2013740. https:\/\/doi.org\/10.1182\/blood-2009-10-251157.","journal-title":"Blood"},{"key":"1112_CR20","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/s0140-6736(03)12513-5","volume":"361","author":"C Antoine","year":"2003","unstructured":"Antoine C, M\u00fcller S, Cant A, Cavazzana-Calvo M, Veys P, Vossen J, et al. Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968\u201399. Lancet. 2003;361:553\u201360. https:\/\/doi.org\/10.1016\/s0140-6736(03)12513-5.","journal-title":"Lancet"},{"key":"1112_CR21","doi-asserted-by":"publisher","first-page":"3615","DOI":"10.1182\/blood-2011-12-396879","volume":"120","author":"A Hassan","year":"2012","unstructured":"Hassan A, Booth C, Brightwell A, Allwood Z, Veys P, Rao R, et al. Outcome of hematopoietic stem cell transplantation for adenosine deaminase-deficient severe combined immunodeficiency. Blood. 2012;120:3615-24-quiz3626. https:\/\/doi.org\/10.1182\/blood-2011-12-396879.","journal-title":"Blood"},{"key":"1112_CR22","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.1182\/blood-2016-11-748616","volume":"129","author":"IJ Abd Hamid","year":"2017","unstructured":"Abd Hamid IJ, Slatter MA, McKendrick F, Pearce MS, Gennery AR. Long-term outcome of hematopoietic stem cell transplantation for IL2RG\/JAK3 SCID: a cohort report. Blood. 2017;129:2198\u2013201. https:\/\/doi.org\/10.1182\/blood-2016-11-748616.","journal-title":"Blood"},{"key":"1112_CR23","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.jaci.2013.01.047","volume":"131","author":"E Haddad","year":"2013","unstructured":"Haddad E, Leroy S, Buckley RH. B-cell reconstitution for SCID: should a conditioning regimen be used in SCID treatment? J Allergy Clin Immunol. 2013;131:994\u20131000. https:\/\/doi.org\/10.1016\/j.jaci.2013.01.047.","journal-title":"J Allergy Clin Immunol"},{"key":"1112_CR24","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1111\/bjh.13497","volume":"170","author":"A Panasiuk","year":"2015","unstructured":"Panasiuk A, Nussey S, Veys P, Amrolia P, Rao K, Krawczuk-Rybak M, et al. Gonadal function and fertility after stem cell transplantation in childhood: comparison of a reduced intensity conditioning regimen containing melphalan with a myeloablative regimen containing busulfan. Br J Haematol. 2015;170:719\u201326. https:\/\/doi.org\/10.1111\/bjh.13497.","journal-title":"Br J Haematol"},{"key":"1112_CR25","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/j.bbmt.2016.05.024","volume":"22","author":"H Allewelt","year":"2016","unstructured":"Allewelt H, El-Khorazaty J, Mendizabal A, Taskindoust M, Martin PL, Prasad V, et al. Late effects after umbilical cord blood transplantation in very young children after busulfan-based, myeloablative conditioning. Biol Blood Marrow Transplant. 2016;22:1627\u201335. https:\/\/doi.org\/10.1016\/j.bbmt.2016.05.024.","journal-title":"Biol Blood Marrow Transplant"},{"key":"1112_CR26","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.bbmt.2016.12.619","volume":"23","author":"J Heimall","year":"2017","unstructured":"Heimall J, Puck J, Buckley R, Fleisher TA, Gennery AR, Neven B, et al. Current knowledge and priorities for future research in late effects after hematopoietic stem cell transplantation (HCT) for severe combined immunodeficiency patients: a consensus statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT. Biol Blood Marrow Transplant. 2017;23:379\u201387. https:\/\/doi.org\/10.1016\/j.bbmt.2016.12.619.","journal-title":"Biol Blood Marrow Transplant"},{"key":"1112_CR27","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1007\/s10875-021-00966-z","volume":"41","author":"A Nishimura","year":"2021","unstructured":"Nishimura A, Aoki Y, Ishiwata Y, Ichimura T, Ueyama J, Kawahara Y, et al. Hematopoietic cell transplantation with reduced intensity conditioning using fludarabine\/busulfan or fludarabine\/melphalan for primary immunodeficiency diseases. J Clin Immunol. 2021;41:944\u201357. https:\/\/doi.org\/10.1007\/s10875-021-00966-z.","journal-title":"J Clin Immunol."},{"key":"1112_CR28","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1016\/j.bbmt.2015.07.008","volume":"21","author":"D Balashov","year":"2015","unstructured":"Balashov D, Shcherbina A, Maschan M, Trakhtman P, Skvortsova Y, Shelikhova L, et al. Single-center experience of unrelated and haploidentical stem cell transplantation with TCR\u03b1\u03b2 and CD19 depletion in children with primary immunodeficiency syndromes. Biol Blood Marrow Transplant. 2015;21:1955\u201362. https:\/\/doi.org\/10.1016\/j.bbmt.2015.07.008.","journal-title":"Biol Blood Marrow Transplant"},{"key":"1112_CR29","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/j.jaci.2017.07.008","volume":"141","author":"RM Shah","year":"2018","unstructured":"Shah RM, Elfeky R, Nademi Z, Qasim W, Amrolia P, Chiesa R, et al. T-cell receptor \u03b1\u03b2+ and CD19+ cell-depleted haploidentical and mismatched hematopoietic stem cell transplantation in primary immune deficiency. J Allergy Clin Immunol. 2018;141:1417-1426.e1. https:\/\/doi.org\/10.1016\/j.jaci.2017.07.008.","journal-title":"J Allergy Clin Immunol"},{"key":"1112_CR30","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jaci.2019.01.030","volume":"144","author":"R Elfeky","year":"2019","unstructured":"Elfeky R, Shah RM, Unni MNM, Ottaviano G, Rao K, Chiesa R, et al. New graft manipulation strategies improve the outcome of mismatched stem cell transplantation in children with primary immunodeficiencies. J Allergy Clin Immunol. 2019;144:280\u201393. https:\/\/doi.org\/10.1016\/j.jaci.2019.01.030.","journal-title":"J Allergy Clin Immunol"},{"key":"1112_CR31","doi-asserted-by":"publisher","first-page":"335ra57","DOI":"10.1126\/scitranslmed.aad8856","volume":"8","author":"SS De Ravin","year":"2016","unstructured":"De Ravin SS, Wu X, Moir S, Anaya-O\u2019Brien S, Kwatemaa N, Littel P, et al. Lentiviral hematopoietic stem cell gene therapy for X-linked severe combined immunodeficiency. Sci Transl Med. 2016;8:335ra57. https:\/\/doi.org\/10.1126\/scitranslmed.aad8856.","journal-title":"Sci Transl Med"},{"key":"1112_CR32","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1056\/NEJMoa1815408","volume":"380","author":"E Mamcarz","year":"2019","unstructured":"Mamcarz E, Zhou S, Lockey T, Abdelsamed H, Cross SJ, Kang G, et al. Lentiviral gene therapy combined with low-dose busulfan in infants with SCID-X1. N Engl J Med. 2019;380:1525\u201334. https:\/\/doi.org\/10.1056\/NEJMoa1815408.","journal-title":"N Engl J Med"},{"key":"1112_CR33","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.1182\/blood-2017-05-781849","volume":"130","author":"J Heimall","year":"2017","unstructured":"Heimall J, Logan BR, Cowan MJ, Notarangelo LD, Griffith LM, Puck JM, et al. Immune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: a PIDTC natural history study. Blood. 2017;130:2718\u201327. https:\/\/doi.org\/10.1182\/blood-2017-05-781849.","journal-title":"Blood"},{"key":"1112_CR34","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/ni0908-1005","volume":"9","author":"PD Burrows","year":"2008","unstructured":"Burrows PD, Fischer A. Building networks for immunodeficiency diseases and immunology training. Nat Immunol. 2008;9:1005\u20137. https:\/\/doi.org\/10.1038\/ni0908-1005.","journal-title":"Nat Immunol"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-021-01112-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-021-01112-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-021-01112-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T23:04:22Z","timestamp":1744153462000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-021-01112-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,27]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["1112"],"URL":"https:\/\/doi.org\/10.1007\/s10875-021-01112-5","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,27]]},"assertion":[{"value":"24 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The studies involving human participants were reviewed and approved by the Institutional Review Boards at the Japanese Society for Transplantation and Cellular Therapy (JSTCT) and Tokyo Medical and Dental University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"All participants (and\/or their guardians) provided written informed consent for research use of their data and publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate\/Publication"}},{"value":"The authors declare no competing interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}